Scott C. Brun - Net Worth and Insider Trading

Scott C. Brun Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Scott C. Brun owns 3 companies in total, including Cabaletta Bio Inc (CABA) , Forte Biosciences Inc (FBRX) , and Jasper Therapeutics Inc (JSPR) .

Click here to see the complete history of Scott C. Brun’s form 4 insider trades.

Insider Ownership Summary of Scott C. Brun

Ticker	Comapny	Transaction Date	Type of Owner
CABA	Cabaletta Bio Inc	2021-06-24	director
FBRX	Forte Biosciences Inc	2022-11-10	director
JSPR	Jasper Therapeutics Inc	2023-06-20	director

Scott C. Brun Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Scott C. Brun Ownership Network

Ownership Network List of Scott C. Brun

No Data

Ownership Network Relation of Scott C. Brun

Scott C. Brun Owned Company Details

What does Cabaletta Bio Inc do?

Who are the key executives at Cabaletta Bio Inc?

Scott C. Brun is the director of Cabaletta Bio Inc. Other key executives at Cabaletta Bio Inc include EVP & Science & Technology Gwendolyn Binder , director & President & CEO Steven Nichtberger , and Chief Financial Officer Anup Marda .

Cabaletta Bio Inc (CABA) Insider Trades Summary

Over the past 18 months, Scott C. Brun made no insider transaction in Cabaletta Bio Inc (CABA). Other recent insider transactions involving Cabaletta Bio Inc (CABA) include a net sale of 110,000 shares made by Gwendolyn Binder ,

In summary, during the past 3 months, insiders sold 0 shares of Cabaletta Bio Inc (CABA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 110,000 shares of Cabaletta Bio Inc (CABA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 110,000 shares.

Cabaletta Bio Inc (CABA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cabaletta Bio Inc Insider Transactions

No Available Data

What does Forte Biosciences Inc do?

Who are the key executives at Forte Biosciences Inc?

Scott C. Brun is the director of Forte Biosciences Inc. Other key executives at Forte Biosciences Inc include director & See Remarks Paul A. Wagner , See remarks Hubert C Chen , and Chief Financial Officer Antony A Riley .

Forte Biosciences Inc (FBRX) Insider Trades Summary

Over the past 18 months, Scott C. Brun made no insider transaction in Forte Biosciences Inc (FBRX). Other recent insider transactions involving Forte Biosciences Inc (FBRX) include a net purchase of 218,865 shares made by Paul A. Wagner ,

In summary, during the past 3 months, insiders sold 0 shares of Forte Biosciences Inc (FBRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Forte Biosciences Inc (FBRX) were sold and 218,865 shares were bought by its insiders, resulting in a net purchase of 218,865 shares.

Forte Biosciences Inc (FBRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Forte Biosciences Inc Insider Transactions

No Available Data

What does Jasper Therapeutics Inc do?

Who are the key executives at Jasper Therapeutics Inc?

Scott C. Brun is the director of Jasper Therapeutics Inc. Other key executives at Jasper Therapeutics Inc include Chief Operating Officer Jeetinder Singh Mahal , 10 percent owner Carlyle Group Inc. , and other: See Footnote 1 Velan Capital Master Fund Lp .

Jasper Therapeutics Inc (JSPR) Insider Trades Summary

Over the past 18 months, Scott C. Brun made no insider transaction in Jasper Therapeutics Inc (JSPR). Other recent insider transactions involving Jasper Therapeutics Inc (JSPR) include a net purchase of 50,000 shares made by Thomas G Wiggans , a net purchase of 3,323,333 shares made by Carlyle Group Inc. , and a net sale of 16,465 shares made by William Lis .

In summary, during the past 3 months, insiders sold 900 shares of Jasper Therapeutics Inc (JSPR) in total and bought 0 shares, with a net sale of 900 shares. During the past 18 months, 12,554 shares of Jasper Therapeutics Inc (JSPR) were sold and 1,125,000 shares were bought by its insiders, resulting in a net purchase of 1,112,446 shares.

Jasper Therapeutics Inc (JSPR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Jasper Therapeutics Inc Insider Transactions

No Available Data

Scott C. Brun Mailing Address

Above is the net worth, insider trading, and ownership report for Scott C. Brun. You might contact Scott C. Brun via mailing address: C/o Cabaletta Bio, Inc., 2929 Arch Street, Suite 600, Philadelphia Pa 19104.

Discussions on Scott C. Brun

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.